143 related articles for article (PubMed ID: 23327795)
1. Mouse models of Mdm2 and Mdm4 and their clinical implications.
Xiong S
Chin J Cancer; 2013 Jul; 32(7):371-5. PubMed ID: 23327795
[TBL] [Abstract][Full Text] [Related]
2. MDMX Recruits UbcH5c to Facilitate MDM2 E3 Ligase Activity and Subsequent p53 Degradation
Yang J; Jin A; Han J; Chen X; Zheng J; Zhang Y
Cancer Res; 2021 Feb; 81(4):898-909. PubMed ID: 33277368
[TBL] [Abstract][Full Text] [Related]
3. Estrogen receptor alpha (ERα/ESR1) mediates the p53-independent overexpression of MDM4/MDMX and MDM2 in human breast cancer.
Swetzig WM; Wang J; Das GM
Oncotarget; 2016 Mar; 7(13):16049-69. PubMed ID: 26909605
[TBL] [Abstract][Full Text] [Related]
4. CDK9 activity is critical for maintaining MDM4 overexpression in tumor cells.
Štětková M; Growková K; Fojtík P; Valčíková B; Palušová V; Verlande A; Jorda R; Kryštof V; Hejret V; Alexiou P; Rotrekl V; Uldrijan S
Cell Death Dis; 2020 Sep; 11(9):754. PubMed ID: 32934219
[TBL] [Abstract][Full Text] [Related]
5. Discovery of JN122, a Spiroindoline-Containing Molecule that Inhibits MDM2/p53 Protein-Protein Interaction and Exerts Robust In Vivo Antitumor Efficacy.
Cheng J; Yan Z; Jiang K; Liu C; Xu D; Lyu X; Hu X; Zhang S; Zhou Y; Li J; Zhao Y
J Med Chem; 2023 Dec; 66(24):16991-17025. PubMed ID: 38062557
[TBL] [Abstract][Full Text] [Related]
6. FAM193A is a positive regulator of p53 activity.
Szwarc MM; Guarnieri AL; Joshi M; Duc HN; Laird MC; Pandey A; Khanal S; Dohm E; Bui AK; Sullivan KD; Galbraith MD; Andrysik Z; Espinosa JM
Cell Rep; 2023 Mar; 42(3):112230. PubMed ID: 36897777
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis gene profiling reveals spatio-temporal regulated expression of the p53/Mdm2 pathway during lens development.
Geatrell JC; Gan PM; Mansergh FC; Kisiswa L; Jarrin M; Williams LA; Evans MJ; Boulton ME; Wride MA
Exp Eye Res; 2009 Jun; 88(6):1137-51. PubMed ID: 19450442
[TBL] [Abstract][Full Text] [Related]
8. Mdm4 supports DNA replication in a p53-independent fashion.
Wohlberedt K; Klusmann I; Derevyanko PK; Henningsen K; Choo JAMY; Manzini V; Magerhans A; Giansanti C; Eischen CM; Jochemsen AG; Dobbelstein M
Oncogene; 2020 Jun; 39(25):4828-4843. PubMed ID: 32427989
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of 4-imidazolidinone-containing compounds as potent inhibitors of the MDM2/p53 interaction.
Lin Z; Liu C; Yan Z; Cheng J; Wang X; Zhou F; Lyu X; Zhang S; Zhang D; Meng X; Zhao Y
Eur J Med Chem; 2024 Apr; 270():116366. PubMed ID: 38581730
[TBL] [Abstract][Full Text] [Related]
10. LncRNA NRON promotes tumorigenesis by enhancing MDM2 activity toward tumor suppressor substrates.
Guo Q; Li Y; Zhang Y; Shen L; Lin H; Chen J; Song E; Luo ML
EMBO J; 2023 Aug; 42(16):e112414. PubMed ID: 37382239
[TBL] [Abstract][Full Text] [Related]
11. Genome Stability Requires p53.
Eischen CM
Cold Spring Harb Perspect Med; 2016 Jun; 6(6):. PubMed ID: 27252396
[TBL] [Abstract][Full Text] [Related]
12. Development and Nanoparticle-Mediated Delivery of Novel MDM2/MDM4 Heterodimer Peptide Inhibitors to Enhance 5-Fluorouracil Nucleolar Stress in Colorectal Cancer Cells.
Merlino F; Pecoraro A; Longobardi G; Donati G; Di Leva FS; Brignola C; Piccarducci R; Daniele S; Martini C; Marinelli L; Russo G; Quaglia F; Conte C; Russo A; La Pietra V
J Med Chem; 2024 Feb; 67(3):1812-1824. PubMed ID: 38285632
[TBL] [Abstract][Full Text] [Related]
13. MDM2 prevents spontaneous tubular epithelial cell death and acute kidney injury.
Thomasova D; Ebrahim M; Fleckinger K; Li M; Molnar J; Popper B; Liapis H; Kotb AM; Siegerist F; Endlich N; Anders HJ
Cell Death Dis; 2016 Nov; 7(11):e2482. PubMed ID: 27882940
[TBL] [Abstract][Full Text] [Related]
14. Fragment-based library generation for the discovery of a peptidomimetic p53-Mdm4 inhibitor.
Boltjes A; Huang Y; van de Velde R; Rijkee L; Wolf S; Gaugler J; Lesniak K; Guzik K; Holak TA; Dömling A
ACS Comb Sci; 2014 Aug; 16(8):393-6. PubMed ID: 24983416
[TBL] [Abstract][Full Text] [Related]
15. Differential requirements for MDM2 E3 activity during embryogenesis and in adult mice.
Humpton TJ; Nomura K; Weber J; Magnussen HM; Hock AK; Nixon C; Dhayade S; Stevenson D; Huang DT; Strathdee D; Blyth K; Vousden KH
Genes Dev; 2021 Jan; 35(1-2):117-132. PubMed ID: 33334825
[TBL] [Abstract][Full Text] [Related]
16. Mdm proteins: critical regulators of embry ogenesis and homeostasis.
Moyer SM; Larsson CA; Lozano G
J Mol Cell Biol; 2017 Jan; 9(1):16-25. PubMed ID: 28093454
[TBL] [Abstract][Full Text] [Related]
17. p53 and Mdm2 act synergistically to maintain cardiac homeostasis and mediate cardiomyocyte cell cycle arrest through a network of microRNAs.
Stanley-Hasnain S; Hauck L; Grothe D; Aschar-Sobbi R; Beca S; Butany J; Backx PH; Mak TW; Billia F
Cell Cycle; 2017; 16(17):1585-1600. PubMed ID: 28745540
[TBL] [Abstract][Full Text] [Related]
18. Suppression of the mouse double minute 4 gene causes changes in cell cycle control in a human mesothelial cell line responsive to ultraviolet radiation exposure.
Bunderson-Schelvan M; Erbe AK; Schwanke C; Pershouse MA
Environ Mol Mutagen; 2009 Dec; 50(9):753-9. PubMed ID: 19472317
[TBL] [Abstract][Full Text] [Related]
19. Antagonizing MDM2 Overexpression Induced by MDM4 Inhibitor CEP-1347 Effectively Reactivates Wild-Type p53 in Malignant Brain Tumor Cells.
Mitobe Y; Suzuki S; Nakagawa-Saito Y; Togashi K; Sugai A; Sonoda Y; Kitanaka C; Okada M
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686602
[TBL] [Abstract][Full Text] [Related]
20. The role of p53 in developmental syndromes.
Bowen ME; Attardi LD
J Mol Cell Biol; 2019 Mar; 11(3):200-211. PubMed ID: 30624728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
